Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
Status:
Completed
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
1)Preliminarily evaluate the treatment effect of Icotinib Hydrochloride Tablets on NF2;
2)Preliminarily evaluate the safety and the patient's tolerance of the treatment of Icotinib;
3)Provide an objective basis for an enlarged randomized double-blind trial.